IAN MITCHELL to Palivizumab
This is a "connection" page, showing publications IAN MITCHELL has written about Palivizumab.
Connection Strength
0.331
-
Outcomes of Infants Receiving Palivizumab Prophylaxis for Respiratory Syncytial Virus in Canada and Italy: An International, Prospective Cohort Study. Pediatr Infect Dis J. 2017 01; 36(1):2-8.
Score: 0.145
-
Palivizumab Adherence and Outcomes in Canadian Aboriginal Children. Pediatr Infect Dis J. 2016 Nov; 35(11):1187-1193.
Score: 0.144
-
The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol. 2010 Aug; 126(2):256-62.
Score: 0.023
-
Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr. 2007 Jul; 151(1):34-42, 42.e1.
Score: 0.019